SPDR S&P Biotech ETF $XBI Holdings Raised by Tidal Investments LLC

Tidal Investments LLC increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1,771.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 109,331 shares of the exchange traded fund’s stock after acquiring an additional 103,489 shares during the period. Tidal Investments LLC owned about 0.17% of SPDR S&P Biotech ETF worth $17,302,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in the company. Avoro Capital Advisors LLC acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $256,053,000. Bank of America Corp DE increased its stake in shares of SPDR S&P Biotech ETF by 13.3% during the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after purchasing an additional 1,700,851 shares during the last quarter. Wells Fargo & Company MN increased its stake in shares of SPDR S&P Biotech ETF by 75.7% during the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after purchasing an additional 1,536,122 shares during the last quarter. OMERS ADMINISTRATION Corp raised its holdings in shares of SPDR S&P Biotech ETF by 42,425.2% during the 4th quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after purchasing an additional 1,187,907 shares in the last quarter. Finally, Morgan Stanley raised its holdings in shares of SPDR S&P Biotech ETF by 8.3% during the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after purchasing an additional 882,718 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 1.6%

XBI stock opened at $156.82 on Friday. The firm has a market cap of $10.24 billion, a PE ratio of 11.47 and a beta of 0.84. SPDR S&P Biotech ETF has a 1 year low of $92.64 and a 1 year high of $169.89. The company has a fifty day simple moving average of $158.35 and a 200 day simple moving average of $141.62.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.